Shire gets an FDA nod for extended-release ADHD drug; An inside look at veteran drug-delivery investor Terry McGuire;

> Laval, Quebec-based Labopharm, a developer of controlled-release drugs, reported a larger loss for the fourth quarter because it nearly doubled certain expenses. Story

> There was a worthy profile story about venture capitalist Terry McGuire of Polaris Venture Partners, a veteran investor in notable drug-delivery startups such as Advanced Inhalation Research (acquired by Alkermes ($ALKS)) and MicroCHIPS. Story

> Ireland-based specialty drug maker Shire ($SHPGY) said it garnered FDA approval of an extended-release formulation of the drug guanfacine for treating attention deficit and hyperactivity disorder. Shire release

> Enlyton, of Columbus, OH, licensed a tumor-seeking monoclonal antibody from ViroMed for enhancing cancer detection and drug delivery. Story

> Read some insights from scientists at the University of Copenhagen and elsewhere about how the surface features of nanoparticles used in drug delivery impact immune responses. Story

> Chinese medical devices maker Mindray Medical International Limited ($MR) has agreed to buy a controlling stake in Shenzhen Shenke Medical Instrument Technical Development Company, one of China's leading producers of infusion pumps. Financial details weren't disclosed. Mindray release

> Vancouver-based QLT Inc. ($QLTI), a developer of plugs inserted at the opening of the tear ducts to deliver eye treatments, reported that its fourth-quarter revenue was down 7.3 percent to $10 million and provided an update on its pipeline. QLT release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.